Submitted by Anonymous (not verified) on 13 January 2026 - 14:43
Human medicines European public assessment report (EPAR): Inrebic, fedratinib, Date of authorisation: 08/02/2021, Revision: 9, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Inrebic, fedratinib, Date of authorisation: 08/02/2021, Revision: 9, Status: Authorised